Editorial – Musculoskeletal pain: Which role for tapentadol?

Maurizio Evangelista, G. Finco, F. Marinangeli

Risultato della ricerca: Contributo in rivistaEditoriale in rivista / quotidianopeer review

Abstract

Chronic pain is defined as pain persisting after healing of an underlying pathology or as persisting pain in the absence of tissue damage. In the last decade, the understanding of mechanisms involved in chronic pain led to an improved approach to patient management, with the aim to reduce discomfort, improve quality of life (QoL) and enhance functional recovery. Chronic musculoskeletal pain, which is frequently encountered in clinical practice, can affect patients of all ages and is particularly common in older patients. Indeed, low back pain is the most frequent chronic pain condition worldwide, with a lifetime prevalence of >70% in western countries1,2. Neck pain is also a common disabling disease, with a prevalence of 23%, and is associated with high costs for medical visits and physiotherapy. Both low back pain and neck pain involve nociceptive and neuropathic pain mechanisms
Lingua originaleEnglish
pagine (da-a)1-4
Numero di pagine4
RivistaEuropean Review for Medical and Pharmacological Sciences
Volume23
DOI
Stato di pubblicazionePubblicato - 2019

Keywords

  • muscoloskeletal pain
  • opioids
  • tapentadol

Fingerprint

Entra nei temi di ricerca di 'Editorial – Musculoskeletal pain: Which role for tapentadol?'. Insieme formano una fingerprint unica.

Cita questo